Abir El-Alfy

Title: Abir El-Alfy: Innovator in Anxiolytic Research

Introduction

Abir El-Alfy is a notable inventor based in Frankfort, IL (US), recognized for his contributions to the field of anxiolytic research. His innovative work focuses on the effects of pterostilbene, a natural analog of resveratrol, on anxiety levels in mice. With a patent to his name, El-Alfy has made significant strides in understanding the anxiolytic properties of this compound.

Latest Patents

El-Alfy holds a patent titled "Anxiolytic effect of pterostilbene." This groundbreaking research reports for the first time that pterostilbene exhibits anxiolytic-like action by downregulating phosphorylated levels of ERKs in the hippocampus of mice. The study demonstrated that mice administered pterostilbene at doses of 1 and 2 mg/kg showed increased percent permanence time and number of entries in open arms during the Elevated-plus maze (EPM) test, indicating reduced anxiety levels. The anxiolytic activity observed was comparable to that of diazepam at similar doses.

Career Highlights

Throughout his career, Abir El-Alfy has worked with various esteemed organizations, including the United States of America, as represented by the Secretary of Agriculture, and the University of Mississippi. His research has contributed to a deeper understanding of how pterostilbene can cross the blood-brain barrier and exert its effects on anxiety.

Collaborations

El-Alfy has collaborated with notable colleagues, including Agnes M Rimando and Md Al Rahim, who have contributed to his research endeavors.

Conclusion

Abir El-Alfy's innovative research on pterostilbene has opened new avenues in the study of anxiety treatment. His work not only highlights the potential of natural compounds in mental health but also emphasizes the importance of continued research in this vital area.